Saroja Pharma Industries India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Saroja Pharma Industries India Limited has submitted a certificate to the stock exchanges in compliance with SEBI's Depositories and Participants Regulations, 2018. This regulatory filing confirms that the company has successfully completed the necessary documentation process required for its securities to be held in electronic form.

For investors, this development is a routine procedural update that ensures the smooth functioning of the company's shareholding structure. It confirms that the shares are properly dematerialized and eligible for trading, which is essential for maintaining transparency and liquidity in the market.

Investors should view this as a standard administrative step rather than a significant market-moving event. The stock price is not expected to be impacted by this specific filing, as it relates to the company's compliance with established regulatory frameworks.